Increased hepatic iron and NASH is linked to a greater prevalence of heterozygosity for the hemochromatosis hepcidin (HFE) mutation in NASH patients [81]. The gene discussed is HAMP; the disease is metabolic dysfunction-associated steatohepatitis.